From: Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981–2000
Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|
Country | Rate | RR* | 95% CI | p | Rate | RR* | 95% CI | p | RR† |
North | |||||||||
Denmark | 7.62 | 1.27 | 1.23 to 1.31 | <0.001 | 4.80 | 1.82 | 1.76 to 1.88 | <0.001 | 1.59 |
Finland | 8.04 | 1.34 | 1.30 to 1.39 | <0.001 | 4.07 | 1.54 | 1.49 to 1.60 | <0.001 | 1.97 |
Norway | 7.16 | 1.19 | 1.15 to 1.24 | <0.001 | 3.47 | 1.32 | 1.26 to 1.38 | <0.001 | 2.06 |
Sweden | 7.92 | 1.32 | 1.29 to 1.35 | <0.001 | 4.59 | 1.74 | 1.69 to 1.79 | <0.001 | 1.72 |
West | |||||||||
Austria | 8.32 | 1.39 | 1.35 to 1.42 | <0.001 | 4.23 | 1.60 | 1.56 to 1.65 | <0.001 | 1.97 |
France | 6.60 | 1.10 | 1.09 to 1.11 | <0.001 | 2.64 | 1.00 | 0.99 to 1.01 | 0.957 | 2.50 |
Ireland | 4.99 | 0.83 | 0.79 to 0.88 | <0.001 | 2.38 | 0.90 | 0.84 to 0.97 | 0.004 | 2.09 |
Netherlands | 7.87 | 1.31 | 1.29 to 1.34 | <0.001 | 3.91 | 1.48 | 1.45 to 1.52 | <0.001 | 2.01 |
UK | 5.63 | 0.94 | 0.93 to 0.95 | <0.001 | 2.63 | 1.00 | 0.98 to 1.01 | 0.522 | 2.14 |
East | |||||||||
Bulgaria | 3.04 | 0.51 | 0.49 to 0.53 | <0.001 | 1.43 | 0.54 | 0.52 to 0.57 | <0.001 | 2.12 |
Hungary | 8.90 | 1.48 | 1.45 to 1.52 | <0.001 | 3.95 | 1.50 | 1.46 to 1.54 | <0.001 | 2.25 |
South | |||||||||
Greece | 3.73 | 0.62 | 0.60 to 0.64 | <0.001 | 1.51 | 0.57 | 0.55 to 0.60 | <0.001 | 2.47 |
Italy | 5.92 | 0.99 | 0.98 to 1.00 | 0.010 | 2.26 | 0.85 | 0.84 to 0.87 | <0.001 | 2.63 |
Spain | 4.14 | 0.69 | 0.68 to 0.70 | <0.001 | 1.59 | 0.60 | 0.59 to 0.61 | <0.001 | 2.61 |